Get started
Author

A. Biasiolo

Observed names: A Biasiolo, Alessandro Biasiolo, Allesandre Biasiolo, BIASIOLO A, Biasiolo A
Institution: University of Padua
OpenAlex ID: A5113566122
Reversal of excessive effect of regular anticoagulation
1993 · V. Pengo, A. Banzato, et al. · Blood Coagulation & Fibrinolysis · 80
dRVVT Is more Sensitive than KCT or TTI for Detecting Lupus Anticoagulant Activity of Anti-β2-glycoprotein I Autoantibodies
1999 · A. Biasiolo, P. Rampazzo, et al. · Thrombosis and Haemostasis · 75
A two‐step coagulation test to identify antiβ2‐glycoprotein I lupus anticoagulants
2004 · V. Pengo, A. Biasiolo, et al. · Journal of Thrombosis and Haemostasis · 70
PDF
A Comparison of a Moderate with Moderate-high Intensity Oral Anticoagulant Treatment in Patients with Mechanical Heart Valve Prostheses
1997 · Vittorio Pengo, Fabio Barbero, et al. · Thrombosis and Haemostasis · 45
Monitoring SCCA‐IgM complexes in serum predicts liver disease progression in patients with chronic hepatitis
2008 · A. Biasiolo, L. Chemello, et al. · Journal of Viral Hepatitis · 38
PDF
Antiphospholipid antibodies are not present in the membrane of gel-filtered platelets of patients with IgG anticardiolipin antibodies, lupus anticoagulant and thrombosis
1993 · A. Biasiolo, V. Pengo · Blood Coagulation & Fibrinolysis · 29
Immunosuppressive treatment in a heart transplantation candidate with antiphospholipid syndrome
1996 · V. Pengo, A. Biasiolo, et al. · Clinical Rheumatology · 11
Initiation of Warfarin Treatment in Outpatients with Nonrheumatic Atrial Fibrillation: A Scheme for Early Indication of Maintenance Dose
1998 · Vittorio Pengo, Antonella Zasso, et al. · Clinical and Applied Thrombosis/Hemostasis · 8
Accelerated Atherosclerosis in the Aortic Arch and Cerebral Ischemia in a Patient with Primary Antiphospholipid Syndrome
2001 · V Pengo, A Zocche, et al. · Elsevier eBooks · 3
Effect of Anti-β2Glycoprotein I Lupus Anticoagulants on Fibrin Polymerization and Fibrinolysis
2000 · V. Pengo, A. Biasiolo, et al. · Autoimmunity · 3
Low intensity warfarin therapy.
1997 · V Pengo, A Zasso, et al. · PubMed · 3
Combining SCCA-IgM and AFP-IgM levels increases accuracy of hepatocellular carcinoma detection
2009 · A. Gallotta, J. Zuin, et al. · Digestive and Liver Disease · 2
Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes a pro-tumorigenic inflammatory response
2023 · B. Foglia, S. Cannito, et al. · Digestive and Liver Disease · 1
New algorithm to identify patients at higher risk to develop hepatocellular carcinoma, based on machine learning approach
2022 · A. Martini, D. Stefanelli, et al. · Digestive and Liver Disease · 1
Effect of Protease-Activated Receptor 2 inhibition by 1-Piperidinepropionic acid in lipid accumulation, inflammation and hepatocellular carcinoma development
2025 · P. Guerra, G. Villano, et al. · Digestive and Liver Disease
1-Piperidine propionic acid is effective in reducing HCC development and fatty acid accumulation in experimental liver carcinogenesis
2024 · P. Guerra, G. Villano, et al. · Digestive and Liver Disease
The CCAAT/Enhancer-Binding Protein beta - SerpinB3 axis inhibition as a novel strategy for Non-Alcoholic Steatohepatitis treatment
2023 · A. Martini, G. Villano, et al. · Digestive and Liver Disease
AB0730 SCCA-IgM as a predictor of interstitial lung disease progression in systemic sclerosis | Annals of the Rheumatic Diseases
2022 · E. Zanatta, A. Martini, et al. · Annals of the Rheumatic Diseases
PDF
SerpinB3/4 expression is associated with poor prognosis in patients with cholangiocarcinoma
2022 · A. Martini, K. Prasai, et al. · Digestive and Liver Disease
P.381 Monitoring SCCA-IgM complex predicts liver disease progression in patients with chronic hepatitis and cirrhosis
2006 · S. Quarta, A. Biasiolo, et al. · Journal of Clinical Virology
Works count: 31
Citation count: 369
H-index: 8
I10-index: 7
Year
Topic
Type